IRELAND WOOD SURGERY
IVESON APPROACH, LEEDS
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 618 | 740 | 83.5% | |
| CKD 4 | 2008 | 619 | 762 | 81.2% | |
| CKD 5 | 2009 | 133 | 169 | 78.7% | |
| CKD 5 | 2010 | 29 | 36 | 80.6% | |
| CKD 5 | 2011 | 24 | 28 | 85.7% | |
| CKD 5 | 2012 | 21 | 25 | 84.0% | |
| CKD 5 | 2013 | 18 | 21 | 85.7% | |
| CKD003 | 2014 | 15 | 16 | 93.8% | |
| CKD003 | 2015 | 13 | 16 | 81.2% | |
| NM84 | 2016 | 12 | 19 | 63.2% | |
| NM84 | 2017 | 12 | 18 | 66.7% | |
| NM84 | 2018 | 11 | 16 | 68.8% | |
| NM84 | 2020 | 13 | 18 | 72.2% | |
| NM84 | 2022 | 12 | 17 | 70.6% | |
| NM84 | 2023 | 14 | 17 | 82.4% |
